Stuart C. Gordon, MD

home / authors / stuart-c-gordon-md

Articles

August 13th 2019

Late Diagnosis of Hepatitis C Virus Infection, 2014-2016: Continuing Missed Intervention Opportunities

Anne C. Moorman, MPH Jian Xing, PhD Loralee B. Rupp, MSE Stuart C. Gordon, MD Mei Lu, PhD Philip R. Spradling, MD Joseph A. Boscarino, PhD Mark A. Schmidt, PhD Yihe G. Daida, PhD Eyasu H. Teshale, MD for the CHeCS Investigators

Late hepatitis C virus infection diagnosis points to a need for earlier screening and treatment before the onset of severe liver disease leading to high cost and diminished outcomes.

February 16th 2017

Treating Medicaid Patients With Hepatitis C: Clinical and Economic Impact

Zobair Younossi, MD Stuart C. Gordon, MD Aijaz Ahmed, MD Douglas Dieterich, MD Sammy Saab, MD Rachel Beckerman, PhD

Hepatitis C virus treatment is often restricted in Medicaid patients. This analysis evaluates the clinical and cost impacts of treating all Medicaid patients versus the current status quo.

May 3rd 2016

Real-World Outcomes of Ledipasvir/Sofosbuvir in Treatment-Naïve Patients With Hepatitis C

Zobair M. Younossi, MD, MPH, FACG, AGAF, FAASLD Haesuk Park, PhD Stuart C. Gordon, MD John R. Ferguson Aijaz Ahmed, MD Douglas Dieterich, MD Sammy Saab, MD, MPH

In the treatment of hepatitis C virus, the gap between efficacy and real-world effectiveness narrows with improved tolerability and ease of use.

April 17th 2014

Hepatitis B Virus Infection Testing and Prevalence Among Asian and Pacific Islanders